Molecular and genetic abnormalities in radial scar

Human Pathology

Volumn 33, Issue 7, 2002, Pages 715-722

  Iqbal, Mussawar ^a,b   Shoker, Balvinder S ^a,b   Foster, Christopher S ^a,b   Jarvis, Christine ^a,b   Sibson, D Ross ^a,b   Davies, Michael P A ^a,b  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Allelic imbalance; Estrogen receptor; Ki67; Radial scar

Indexed keywords

DNA; ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SCAR;

EID: 0036650470     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.125375     Document Type: Article

References (25)

1. Sclerosing papillary proliferations in the female breast. A benign lesion often mistaken for carcinoma
2. A non-capsulated sclerosing lesion of the breast
3. Radial scar of benign and malignant breast: Comparative features and significance
4. Radial scar in the female breast: A long-term follow-up of 32 cases
5. Risk factors for breast cancer in women with proliferative breast disease
6. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: Importance of lesion size and patient age
7. Radial scars in benign breast biopsy specimens and the risk of breast cancer
8. Oestrogen receptor expression in normal and pre-cancerous breast
9. Estrogen receptor-positive proliferating cells in the normal and precancerous breast
10. Abnormal regulation of oestrogen receptor in benign breast lesions
11. Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor positive cells
12. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor α and Ki-67 expression
13. Histological types of benign breast lesions and the risk of breast cancer: Case-control study
14. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
15. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast
16. Atypical ductal hyperplasia of the breast: Clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p
17. Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy
18. Loss of heterozygosity in fibrocystic change of the breast
19. Allelotyping of ductal carcinoma in situ of the breast: Deletion of loci on 8p, 13q, 16q, 17p, and 17q
20. Comparative allelotype of in situ and invasive human breast cancer: High frequency of microsatellite instability in lobular breast carcinomas
21. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer
22. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer
23. Cellular changes involved in conversion of normal to malignant breast: Importance of stromal reaction
24. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution
25. Influence of mentrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast